Nordhaven advised NFD in the sale of their shares in VESO

5 june 2019

Nordhaven Corporate Finance acted as exclusive financial advisor to the Norwegian Ministry of Trade, Industry and Fisheries (Nærings- og Fiskeridepartementet – NFD) in the sale of their 34 % share in Veterinærmedisinsk Oppdragssenter AS (VESO), to Aquanova Invest AS.

For further information regarding the sale, see the press release from the Norwegian Ministry of Trade, Industry and Fisheries: https://www.regjeringen.no/no/aktuelt/staten-har-solgt-seg-ut-av-veterinarmedisinsk-oppdragssenter-as-veso/id2652739/.

About VESO

VESO was established by the Norwegian Agricultural Research Council 1988. The company has two business areas: distribution of pharmaceuticals for animals in the Norwegian market and clinical infection tests on fish in connection with vaccine development, feed development and breeding. The company is headquartered in Oslo, with distribution centres in Oslo, Vestby and Puerto Varas in Chile, while the clinical laboratory for fish infections is located outside Namsos in Trøndelag, and Colaco in Chile. The company's operating revenue, including subsidiaries, totalled MNOK 567 for 2018 with an EBITDA of MNOK 14.

Join our newsletter
Subscribe to our newsletter to receive the latest news from Nordhaven Corporate Finance.
  • Helsinki
  • Eteläranta 12
  • +35 8 207 613 910
  • Oslo
  • Hieronymus Heyerdahls gate 1
  • +47 21 50 70 00
  • Stockholm
  • Birger Jarlsgatan 14
  • +46 72 318 48 50
 
Contact LinkedinPrivacy Policy
Nordhaven
Website by Almedialt